Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effect of Eligibility Criteria on Patients’ Survival and Serious Adverse Events in Colorectal Cancer Drug Trials

Chang Wang, Aokun Chen, Xing He, Patrick Balian, Thomas J. George, Fei Wang, View ORCID ProfileJiang Bian, View ORCID ProfileYi Guo
doi: https://doi.org/10.1101/2024.04.03.24305265
Chang Wang
1University of Florida, Gainesville, Florida, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aokun Chen
1University of Florida, Gainesville, Florida, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xing He
1University of Florida, Gainesville, Florida, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Balian
1University of Florida, Gainesville, Florida, USA
DBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas J. George
1University of Florida, Gainesville, Florida, USA
MD, FACP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fei Wang
2Weill Cornell Medicine, New York, New York, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiang Bian
1University of Florida, Gainesville, Florida, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jiang Bian
  • For correspondence: yiguo{at}ufl.edu bianjiang{at}ufl.edu
Yi Guo
1University of Florida, Gainesville, Florida, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yi Guo
  • For correspondence: yiguo{at}ufl.edu bianjiang{at}ufl.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

All data produced in the present work are contained in the manuscript

Back to top
PreviousNext
Posted April 03, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effect of Eligibility Criteria on Patients’ Survival and Serious Adverse Events in Colorectal Cancer Drug Trials
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effect of Eligibility Criteria on Patients’ Survival and Serious Adverse Events in Colorectal Cancer Drug Trials
Chang Wang, Aokun Chen, Xing He, Patrick Balian, Thomas J. George, Fei Wang, Jiang Bian, Yi Guo
medRxiv 2024.04.03.24305265; doi: https://doi.org/10.1101/2024.04.03.24305265
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Effect of Eligibility Criteria on Patients’ Survival and Serious Adverse Events in Colorectal Cancer Drug Trials
Chang Wang, Aokun Chen, Xing He, Patrick Balian, Thomas J. George, Fei Wang, Jiang Bian, Yi Guo
medRxiv 2024.04.03.24305265; doi: https://doi.org/10.1101/2024.04.03.24305265

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Informatics
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)